Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 18, 2008
Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors
Thaddeus J Wadas, Martin Eiblmaier, Alexander Zheleznyak, et al.
Research Square
|
June 5, 2025
Advanced Quantification Pipeline Reveals New Spatial and Temporal Tumor Characteristics in Preclinical Multiple Myeloma
Zhixin Sun, Jacqueline Godbe, Alexander Zheleznyak, et al.
Molecular Pharmaceutics
|
July 25, 2014
Evaluation of (89)Zr-pertuzumab in Breast cancer xenografts
Bernadette V Marquez, Oluwatayo F Ikotun, Alexander Zheleznyak, et al.
Plos One
|
February 15, 2013
Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myeloma
Deepti Soodgupta, Michelle A Hurchla, Majiong Jiang, et al.
Nuclear Medicine and Biology
|
July 4, 2016
Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM
Xingyu Nie, Gwendalyn J Randolph, Andrew Elvington, et al.
Molecular Imaging and Biology
|
August 20, 2011
Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation
Alexander Zheleznyak, Thaddeus J Wadas, Christopher D Sherman, et al.
EJNMMI Research
|
July 31, 2025
Advanced quantification pipeline reveals new spatial and temporal tumor characteristics in preclinical multiple myeloma
Zhixin Sun, Jacqueline M Godbe, Alexander Zheleznyak, et al.
Theranostics
|
August 2, 2021
Orthogonal targeting of osteoclasts and myeloma cells for radionuclide stimulated dynamic therapy induces multidimensional cell death pathways
Alexander Zheleznyak, Matthew Mixdorf, Lynne Marsala, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 13, 2012
Molecular imaging of very late antigen-4 (α4β1 integrin) in the premetastatic niche
Monica Shokeen, Alexander Zheleznyak, Jessica M Wilson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 16, 2011
In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer
Kimberly A Lears, Riccardo Ferdani, Kexian Liang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 18, 2008
Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors
Thaddeus J Wadas, Martin Eiblmaier, Alexander Zheleznyak, et al.
Research Square
|
June 5, 2025
Advanced Quantification Pipeline Reveals New Spatial and Temporal Tumor Characteristics in Preclinical Multiple Myeloma
Zhixin Sun, Jacqueline Godbe, Alexander Zheleznyak, et al.
Molecular Pharmaceutics
|
July 25, 2014
Evaluation of (89)Zr-pertuzumab in Breast cancer xenografts
Bernadette V Marquez, Oluwatayo F Ikotun, Alexander Zheleznyak, et al.
Plos One
|
February 15, 2013
Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myeloma
Deepti Soodgupta, Michelle A Hurchla, Majiong Jiang, et al.
Nuclear Medicine and Biology
|
July 4, 2016
Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM
Xingyu Nie, Gwendalyn J Randolph, Andrew Elvington, et al.
Molecular Imaging and Biology
|
August 20, 2011
Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation
Alexander Zheleznyak, Thaddeus J Wadas, Christopher D Sherman, et al.
EJNMMI Research
|
July 31, 2025
Advanced quantification pipeline reveals new spatial and temporal tumor characteristics in preclinical multiple myeloma
Zhixin Sun, Jacqueline M Godbe, Alexander Zheleznyak, et al.
Theranostics
|
August 2, 2021
Orthogonal targeting of osteoclasts and myeloma cells for radionuclide stimulated dynamic therapy induces multidimensional cell death pathways
Alexander Zheleznyak, Matthew Mixdorf, Lynne Marsala, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 13, 2012
Molecular imaging of very late antigen-4 (α4β1 integrin) in the premetastatic niche
Monica Shokeen, Alexander Zheleznyak, Jessica M Wilson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 16, 2011
In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer
Kimberly A Lears, Riccardo Ferdani, Kexian Liang, et al.
Page
of 3